Dexmedetomidine Hydrochloride Injection — FDA Drug Shortage
The FDA lists a drug shortage record for Dexmedetomidine Hydrochloride Injection (injection) from Somerset Therapeutics, LLC with status Current. The shortage was first posted on 04/10/2020.
Shortage Details
- Status
- Current
- Company
- Somerset Therapeutics, LLC
- Package NDC
- 70069-759-04
- Dosage Form
- Injection
- Presentation
- Dexmedetomidine Hydrochloride, Injection, 100 ug/1 mL (NDC 70069-759-04)
- Initial Posting
- 04/10/2020
- Revised Date